Abstract
As in other malignant tumors, prognosis in renal cell carcinoma (RCC) depends on tumor extent and metastasis at the time of primary diagnosis. Staging systems formalize the way in which the extent of RCC is being described and classified. Primary staging of RCC aims at evaluating surgical options. Since surgical excision, which is the mainstay of therapy in non-metastatic RCC, and, recently, minimally invasive ablation methods have evolved significantly over the last decades, staging systems continue to evolve along the way. The 40-year-old Robson classification has been replaced with the TNM classification of RCC, because the latter adapts more easily to changing patterns of diagnosis and therapy. Modern cross-sectional imaging methods, such as multidetector-row computed tomography (MDCT), and magnetic resonance imaging (MRI), perform highly in T-staging of local tumor extent and M-staging of distant metastasis. However, both MDCT and MRI perform poorly in N-staging of lymphadenopathy. At present, 18-F-desoxy-glucose positron emission tomography (FDG-PET) appears to be unreliable in the detection of RCC and its metastasis. This overview of current radiological and surgical literature attempts to describe how modern staging systems for RCC are organized, and which radiological and surgical developments currently influence the way in which primary staging and prognosis of RCC depend on one another.
Similar content being viewed by others
References
Atzpodien J et al (2003) Aktuelle Therapiestrategien beim Nierenzellkarzinom. Uni-Med Science, Bremen, London, Boston
Oberneder R, Wagner H, Siebels M, Stieber P, Busch M, Weiss M (2003) Nierenzellkarzinom. In: Liedl B (ed) Urogenitale Tumoren. Manual Tumorzentrum München, 3rd edn. W. Zuckschwerdt, München, Wien, New York, pp 79–97
Rouviere O, Brunereau L, Lyonnet D, Rouleau P (2002) Staging and follow-up of renal cell carcinoma. J Radiol 83:805–822, discussion 823–824
Sengupta S, Zincke H (2005) Lessons learned in the surgical management of renal cell carcinoma. Urology 66(5 Suppl):36–42
Robson CJ (1963) Radical nephrectomy for renal cell carcinoma. J Urol 89:37–42
Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301
Hermanek P, Schrott KM (1990) Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. J Urol 144:238–242
Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A (2000) Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163:1090–1095
Shuch B, Lam JS, Belldegrun AS (2006) Open partial nephrectomy for the treatment of renal cell carcinoma. Curr Urol Rep 7:31–38
Lee VT, Yip SK, Tan PH, Siow WY, Lau WK, Cheng CW (2006) Renal cell carcinoma of 4 cm or less: an appraisal of its clinical presentation and contemporary surgical management. Asian J Surg 29:40–43
Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stockle M (2006) Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients. Eur Urol 49:308–313
Catalano C, Fraioli F, Laghi A, Napoli A, Pediconi F, Danti M, Nardis P, Passariello R (2003) High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol 180:1271–1277
Yaycioglu O, Rutman MP, Balasubramaniam M, Peters KM, Gonzalez JA (2002) Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors. Urology 60:33–38
Hsu RM, Chan DY, Siegelman SS (2004) Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol 182:551–557
Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM (2004) The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172:63–65
Roy C Sr, El Ghali S, Buy X, Lindner V, Lang H, Saussine C, Jacqmin D (2005) Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study. AJR Am J Roentgenol 184:113–120
Kamel IR, Hochman MG, Keogan MT, Eng J, Longmaid HE 3rd, DeWolf W, Edelman RR (2004) Accuracy of breath-hold magnetic resonance imaging in preoperative staging of organ-confined renal cell carcinoma. J Comput Assist Tomogr 28:327–332
Hallscheidt PJ, Fink C, Haferkamp A, Bock M, Luburic A, Zuna I, Noeldge G, Kauffmann G (2005) Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr 29:64–68
Lawrentschuk N, Gani J, Riordan R, Esler S, Bolton DM (2005) Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 96:291–295
Gupta NP, Ansari MS, Khaitan A, Sivaramakrishna MS, Hemal AK, Dogra PN, Seth A (2004) Impact of imaging and thrombus level in management of renal cell carcinoma extending to veins. Urol Int 72:129–134
Ciancio G, Soloway MS (2005) Renal cell carcinoma with tumor thrombus extending above diaphragm: avoiding cardiopulmonary bypass. Urology 66:266–270
Zini L, Haulon S, Decoene C, Amara N, Villers A, Biserte J, Leroy X, Koussa M (2005) Renal cell carcinoma associated with tumor thrombus in the inferior vena cava: surgical strategies. Ann Vasc Surg 19:522–528
Jibiki M, Iwai T, Inoue Y, Sugano N, Kihara K, Hyochi N, Sunamori M (2004) Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava. J Vasc Surg 39:829–835
Kaplan S, Ekici S, Dogan R, Demircin M, Ozen H, Pasaoglu I (2002) Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Am J Surg 183:292–299
Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS (2004) Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 171:588–591
Moinzadeh A, Libertino JA (2004) Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol 171:598–601
Ergen FB, Hussain HK, Caoili EM, Korobkin M, Carlos RC, Weadock WJ, Johnson TD, Shah R, Hayasaka S, Francis IR (2004) MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. AJR Am J Roentgenol 182:217–225
Rohde V (2006) Nierenzellkarinom. In: Schmelz HU, Sparwasser C, Weidner W (eds) Facharztwissen Urologie. Springer Medizin Verlag, Heidelberg pp 146–158
Seto E, Segall GM, Terris MK (2000) Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan. Urology 55:286
Jadvar H, Kherbache HM, Pinski JK, Conti PS (2003) Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma. Clin Nephrol 60:395–400
Desai MM, Gill IS (2002) Current status of cryoablation and radiofrequency ablation in the management of renal tumors. Curr Opin Urol 12:387–393
Hegarty NJ, Gill IS, Desai MM, Remer EM, O’Malley CM, Kaouk JH (2006) Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 68(1 Suppl):7–13
Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA (2006) Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 20:569–573
Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR (2005) Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185:64–71
Mejean A, Correas JM, Thiounn N, Chretien Y, Helenon O, Dufour B, Grenier N (2006) Conservative treatment of kidney cancer by cryoablation and radiofrequency. Prog Urol 16:101–104
Sabharwal R, Vladica P (2006) Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors. Cardiovasc Intervent Radiol 29:202–209
Marchal F, Brunaud L, Bazin C, Boccacini H, Henrot P, Troufleau P, Krakowski I, Regent D (2006) Radiofrequency ablation in palliative supportive care: early clinical experience. Oncol Rep 15:495–499
Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR (2005) Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 185:72–80
Quaia E, Bussani R, Cova M, Mucelli RP (2005) Radiologic-pathologic correlations of intratumoral tissue components in the most common solid and cystic renal tumors. Pictorial review. Eur Radiol 15:1734–1744
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper is based upon the European Congress of Radiology (ECR) 2006 categorical course CC 1216, Primary Tumor Staging (4): Urological Cancers, A. Kidney.
Rights and permissions
About this article
Cite this article
Mueller-Lisse, U.G., Mueller-Lisse, U.L., Meindl, T. et al. Staging of renal cell carcinoma. Eur Radiol 17, 2268–2277 (2007). https://doi.org/10.1007/s00330-006-0554-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-006-0554-1